Puerto Rico hosted its inaugural Puerto Rico Psychedelic Summit 2025 (PSPR25), bringing together researchers, clinicians, community advocates, policymakers, and psychedelic enthusiasts to explore the role of psychedelic medicines in mental health and their policy and cultural frameworks. Organized by the Pravan Foundation and held primarily in Spanish with translation available, the summit represented a milestone as the island’s first large-scale gathering devoted to bridging science, policy, heritage, and community in psychedelic medicine.
Leadership and Strategic Vision
The Pravan Foundation, co-led by Executive Director David Melchor and Medical Director Dr. Tania Rivera, is spearheading the movement to integrate mental health, psychedelic therapies, and public education in Puerto Rico. According to Melchor, the foundation has shifted psychedelic conversations in Puerto Rico “from the margins to the mainstream,” transforming what was once a taboo subject into a “structured, evidence-driven discussion.” In advance of PSPR25, Pravan announced plans to partner with the University of Puerto Rico Medical Sciences Campus to initiate clinical research into psychedelic therapies, starting with ketamine and potentially expanding to other compounds.
Summit Content and Perspectives
Featured speakers included attorney Sean T. McAllister on policy and legal frameworks, Dr. Paulina Rullán on ketamine-assisted psychotherapy, and presentations on psilocybin psychotherapy and MDMA-assisted therapy. Presentations also covered ibogaine for veterans and addiction, end-of-life psychedelic care, and ancestral practices. According to attendee Salvador Verduzco, presentations emphasizing culturally rich perspectives on indigenous plant medicine practices were particularly impactful, showing “how these plants serve as connections to inner divinity and nature.”
Policy and Future Considerations
The legal status of psychedelics in Puerto Rico currently mirrors U.S. federal policy, with psilocybin and other classical psychedelics remaining illegal Schedule I substances. However, organizers see the island as a potential testbed for psychedelic policy and research, with opportunities to develop clinical infrastructure and regulatory models locally. Attendees emphasized agreement that psychedelic experiences must be tailored to individual psychological needs and cultural context, with broad interest in orienting consumption as medicinal or intentional rather than recreational.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.lucid.news/psychedelic-renaissance-reaches-puerto-rico/